Related Experiment Video
Updated: Feb 21, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis
Ilaria Stadiotti1, Valentina Catto2, Michela Casella2
1Vascular Biology and Regenerative Medicine Unit, Centro Cardiologico Monzino-IRCCS, via Parea 4, 20138, Milan, Italy.
Insights
Arrhythmogenic cardiomyopathy involves fibro-fatty tissue replacing heart muscle, leading to arrhythmias. Identifying the specific cells causing this adipose replacement is key to understanding disease mechanisms and developing new therapies for this genetic heart condition.
Area of Science:
- Cardiology
- Genetics
- Cell Biology
Background:
- Arrhythmogenic cardiomyopathy (ACM) is a genetic heart disease.
- It's characterized by fibro-fatty tissue replacing ventricular myocardium.
- This replacement leads to arrhythmias and sudden cardiac death.
Purpose of the Study:
- To systematically review cell types implicated in adipose replacement in ACM.
- To clarify the cellular origins of ACM substrate defects.
- To identify potential therapeutic targets for ACM.
Main Methods:
- Systematic literature review.
- Analysis of studies investigating cell types in ACM pathogenesis.
- Overview of historical and current cellular theories.
Main Results:
- The precise cell(s) responsible for adipose replacement in ACM remain debated.
- Various cell types have been proposed as key players over time.
- Understanding the cellular source is crucial for mechanistic insights.
Conclusions:
- Identifying the specific cell type driving adipose replacement in ACM is critical.
- This knowledge can advance mechanistic studies of ACM.
- It may reveal novel therapeutic strategies for this genetic cardiac condition.
Abstract:
Arrhythmogenic cardiomyopathy (ACM) is a genetic cardiac condition characterized by the replacement of the ventricular myocardium with fibro-fatty tissue, by arrhythmias and sudden death. Adipogenesis in ACM is considered an aberrant remodeling following myocardial loss. Which cell type(s) is (are) responsible for the adipose replacement is still matter of debate. A systematic overview of the different cells that have been, over time, considered as main players in adipose replacement is provided. The comprehension of the cellular component giving rise to arrhythmogenic cardiomyopathy substrate defects may represent both an essential tool for mechanistic studies of disease pathogenesis and a novel possible therapeutic target.
More Related Videos
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Pathophysiology of Cardiac Performance
Mechanism of Cardiac Arrhythmias